Poonam Keshav
Overview
Explore the profile of Poonam Keshav including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
91
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keshav P, Goyal D, Kaur S
Med Microbiol Immunol
. 2022 Nov;
212(1):35-51.
PMID: 36399160
Parasite of genus Leishmania viz. L. donovani and L. infantum cause visceral leishmaniasis (VL) or Kala-azar, systemic disease with significant enlargement of the liver and spleen, weight loss, anemia, fever...
2.
Keshav P, Goyal D, Kaur S
Curr Res Parasitol Vector Borne Dis
. 2022 Mar;
1:100040.
PMID: 35284854
In this study, we explored (CM), a Trans-Himalayan plant for its chemical components by GC-MS, phytochemical quantitation, and anti-leishmanial efficacy against sensitive strain (SS) and resistant strain (RS) promastigotes of...
3.
Keshav P, Goyal D, Kaur S
J Parasit Dis
. 2021 Nov;
45(4):1002-1013.
PMID: 34789984
Looming drug resistance cases of leishmaniasis infection are an undeniably serious danger to worldwide public health, also jeopardize the efficacy of available drugs. Besides this, no successful vaccine is available...
4.
Keshav P, Goyal D, Kaur S
Parasite Immunol
. 2021 Aug;
43(10-11):e12875.
PMID: 34347892
The menace of the enfeebling disease leishmaniasis prevails due to the inaccessibility of effective vaccine and chemotherapy. Hence in the pursuit of finding novel alternative options with reasonable efficacy, immunomodulation,...
5.
Goyal D, Keshav P, Kaur S
Microb Pathog
. 2021 Jun;
158:105021.
PMID: 34089789
Morbid infection of leishmaniasis is posing threat to humankind due to its exacerbating prevalence in newer emerging areas. Moreover, the availability of limited drugs, their toxicity, limited efficacy, the emergence...
6.
Goyal D, Keshav P, Kaur S
Infect Genet Evol
. 2021 May;
93:104947.
PMID: 34052416
Tropical and subtropical areas of the world are affected by leishmaniasis, which is caused by Leishmania spp. It has been categorized as an NTD (neglected tropical disease) because of its...
7.
Goyal D, Keshav P, Kaur S
Immunobiology
. 2021 Feb;
226(2):152057.
PMID: 33545508
Visceral leishmaniasis (VL) is a neglected tropical disease caused by Leishmania donovani or Leishmania infantum. Currently, the patients are treated with chemotherapeutic drugs; however, their toxicity limits their use. It...
8.
Goyal D, Keshav P, Kaur S
Microb Pathog
. 2021 Jan;
151:104733.
PMID: 33484811
Kinteoplastid protozoan parasite of genus Leishmania is the pathogen that causes leishmaniasis. Its prevalence is highest after malaria and visceral leishmaniasis is the most dreaded form of infection. No vaccine...
9.
Amdekar S, Singh V, Singh R, Sharma P, Keshav P, Kumar A
J Clin Immunol
. 2010 Sep;
31(2):147-54.
PMID: 20838859
This study evaluated the therapeutic efficacy of Lactobacillus casei in treating rheumatoid arthritis using collagen-induced arthritis (CIA) animal model. Healthy female Wistar rats (weight-180-200 g) were included in this study....